|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 31/711 | (2006.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 47/10 | (2006.01) | ||
| A61K 48/00 | (2006.01) |
| (11) | Number of the document | 2444065 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11180358.1 |
| Date of filing the European patent application | 2007-10-31 | |
| (97) | Date of publication of the European application | 2012-04-25 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-17 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 556503 | 2006-11-03 | US |
| (72) |
Trogden, John T., US
Lyons, Robert T., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |